Portugal likely faces another minority government after an inconclusive snap parliamentary election, which risks complicating ...

The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio test is an accurate, minimally invasive, accessible measurement of pTau 217 and β-Amyloid 1-42 concentrations in plasma as a proxy for the ...

MALVERN, Pa., & TOKYO — Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse ® G pTau 217/β-Amyloid 1-42 Plasma Ratio ...

"We designed our Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio test to help physicians and patients with signs and symptoms of cognitive decline obtain an AD diagnosis much earlier when ...

The test calculates a ratio of two proteins ... Less than 20% of cases received an inconclusive result, the FDA said. In a news release, the FDA said the test can "reliably predict the presence ...

Your clinician then compares your test results to normal ranges – and ... and to evaluate risk of developing heart disease. This ratio is used in Australia to assess risk of heart disease.

In the court documents, the defense argues that testing was done on Madison Mogen's fingernail clippings and a "likelihood ratio ... were inconclusive. The results of the test have been redacted ...

The Equity to Asset Ratio (EAR) is a financial metric that measures the proportion of a company’s assets that are financed by its shareholders’ equity. This ratio gives investors and analysts ...

What Is the CD4:CD8 Ratio Test Used For? CD4 and CD8 are two types of white blood cells in your blood. White blood cells help your body fight infections. If you have HIV infection, your doctor may ...

In the new study, the p-tau217 test was combined with another blood biomarker for Alzheimer’s called the amyloid 42/40 ratio, which measures two types of amyloid proteins, another biomarker of ...